Ebselen as a novel IMPase inhibitor as a lithium mimetic

Ebselen as a novel IMPase inhibitor as a lithium mimetic

Bibliographic Details
Main Authors:	Churchill, G, Singh, N, Vasudevan, S, Thomas, J, Halliday, A, Antoniadou, I, Sharp, T, Sharpley, A, Cowen, P
Format:	Conference item
Published:	2014

Similar Items

Behavioural characterisation of ebselen; a potential lithium-mimetic
by: Singh, N, et al.
Published: (2014)

Effects of the potential lithium-mimetic, ebselen, on impulsivity and emotional processing
by: Masaki, C, et al.
Published: (2016)

Effect of the Putative Lithium Mimetic Ebselen on Brain Myo-Inositol, Sleep, and Emotional Processing in Humans
by: Singh, N, et al.
Published: (2015)

Effect of the putative lithium mimetic ebselen on brain myo-inositol, sleep, and emotional processing in humans
by: Singh, N, et al.
Published: (2016)

Effects of the potential lithium-mimetic, ebselen, on brain neurochemistry: a magnetic resonance spectroscopy study at 7 tesla
by: Masaki, C, et al.
Published: (2016)

The putative lithium-mimetic ebselen reduces impulsivity in rodent models
by: Barkus, C, et al.
Published: (2018)

Investigation of the neurochemical, molecular and behavioural properties of the putative lithium-mimetic, ebselen
by: Antoniadou, I
Published: (2015)

Ebselen has lithium‐like effects on central 5‐HT2A receptor function
by: Antoniadou, I, et al.
Published: (2018)

A safe lithium mimetic for bipolar disorder.
by: Singh, N, et al.
Published: (2013)

Identification of lithium mimetic that inhibits inositol monophosphatase for the treatment of bipolar disorder
by: Singh, N, et al.
Published: (2011)

A safe lithium mimetic? The inositol depletion hypothesis rescues an experimental drug for bipolar disorder
by: Churchill, G, et al.
Published: (2013)

Investigating the effects of the lithium-mimetic drug, ebselen, on emotional processing and brain neurochemistry in patients with medication-resistant depression
by: Ramli, FF
Published: (2024)

Exploring Calbindin-IMPase fusion proteins structure and activity
by: James W. Noble, et al.
Published: (2022-07-01)

The potential use of ebselen in treatment-resistant depression
by: Ramli, FF, et al.
Published: (2022)

The Potential Use of Ebselen in Treatment-Resistant Depression
by: Fitri Fareez Ramli, et al.
Published: (2022-04-01)

Entrevista con Enrique García: impases en el desarrollo de América Latina
by: Pedro B. A. DALLARI
Published: (2020-09-01)

Antibacterial Activity of Ebselen
by: Marta Maślanka, et al.
Published: (2023-01-01)

Metallocenyl derivatives of ebselen are selective and competitive inhibitors of thioredoxin reductase
by: Koh, Wei Xiang, et al.
Published: (2022)

Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs
by: Wang Y, et al.
Published: (2017-05-01)

Los impases de los “derechos de propiedad”: el enfoque de la historia
by: Pablo F. Luna
Published: (2023-12-01)

Effect of nefazodone and lithium on sleep architecture in healthy men
by: Sharpley, A, et al.
Published: (1996)

Chemistry Related to the Catalytic Cycle of the Antioxidant Ebselen
by: Kai N. Sands, et al.
Published: (2023-04-01)

Is Ebselen A Therapeutic Target in Fracture Healing?
by: Ahmet Kose, et al.
Published: (2020-06-01)

Effects of ebselen addition on emotional processing and brain neurochemistry in depressed patients unresponsive to antidepressant medication
by: Ramli, FF, et al.
Published: (2024)

Identification and characterisation of a lithium mimetic: enzymatic, cellular and animal investigations
by: Singh, N
Published: (2012)

Targeting the Mycobacterium tuberculosis transpeptidase LdtMt2 with cysteine-reactive inhibitors including ebselen
by: De Munnik, M, et al.
Published: (2019)

Ebselen oxide and derivatives are new allosteric HER2 inhibitors for HER2‐positive cancers
by: Lucas Blasquez, et al.
Published: (2023-10-01)

Melatonin and MitoEbselen-2 Are Radioprotective Agents to Mitochondria
by: Tsutomu Shimura, et al.
Published: (2022-12-01)

Ebselen Interferes with Alzheimer’s Disease by Regulating Mitochondrial Function
by: Xuexia Li, et al.
Published: (2022-07-01)

Ebselen and Analogues: Pharmacological Properties and Synthetic Strategies for Their Preparation
by: Claudio Santi, et al.
Published: (2021-07-01)

Convergent Synthesis of Two Fluorescent Ebselen-Coumarin Heterodimers
by: Jim Küppers, et al.
Published: (2016-07-01)

Characterization of synergistic antibacterial effect of silver nanoparticles and ebselen
by: Xueqing Chen, et al.
Published: (2019-12-01)

Repurposing ebselen for decolonization of vancomycin-resistant enterococci (VRE).
by: Ahmed AbdelKhalek, et al.
Published: (2018-01-01)

Discovery and mechanism studies of a novel ATG4B inhibitor Ebselen by drug repurposing and its anti-colorectal cancer effects in mice
by: Huazhong Xie, et al.
Published: (2022-12-01)

Lithium increases slow wave sleep: possible mediation by brain 5-HT2 receptors?
by: Friston, K, et al.
Published: (1989)

Investigating the neurochemistry of depression and the novel mood stabilising agent, ebselen, using magnetic resonance spectroscopy
by: Masaki, C
Published: (2016)

Ebselen Optimized the Therapeutic Effects of Silver Nanoparticles for Periodontal Treatment
by: Liang Y, et al.
Published: (2023-12-01)

In Vitro Anti-Prostate Cancer Activity of Two Ebselen Analogues
by: Katarzyna B. Kaczor-Keller, et al.
Published: (2020-03-01)

Repurposing Clinical Molecule Ebselen to Combat Drug Resistant Pathogens.
by: Shankar Thangamani, et al.
Published: (2015-01-01)

Nefazodone--a novel antidepressant--may increase REM sleep.
by: Sharpley, A, et al.
Published: (1992)